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Multidrug resistance (MDR)-type transporters medi-
ate the active extrusion of structurally and functionally
dissimilar compounds from the cells, thereby rendering
cells resistant to a range of drugs. The ydaG and ydbA
genes of Lactococcus lactis encode two ATP-binding cas-
sette half-transporters, which both share homology with
MDR proteins such as LmrA from L. lactis or the mam-
malian P-glycoprotein. The ydaG/ydbA genes were
cloned and expressed separately and jointly in L. lactis
using the nisin-inducible system. When both proteins
are co-expressed, several structurally dissimilar drugs
such as ethidium, daunomycin, and BCECF-AM are ex-
truded from the cell. YdaG and YdbA could be co-puri-
fied as a stable heterodimer. ATPase activity was found
to be associated with the YdaG/YdbA heterodimer only
and not with the individual subunits. Both the ydaG and
ydbA genes are up-regulated in multidrug-resistant
L. lactis strains selected for growth in the presence of a
variety of toxic compounds. This is the first demonstra-
tion of a functional heterodimeric ATP-binding cassette-
type MDR transporter.
Multidrug resistance is a phenomenon that has first been
attributed to the active efflux of drugs that renders tumor cells
resistant toward structurally unrelated compounds, thereby
causing a serious problem in chemotherapy of cancer (1). Later,
it was realized that similar transporters in bacteria are respon-
sible for multiple resistance to antibiotics and other toxic com-
pounds (2). The wide spread of (multi)drug-resistant microor-
ganisms is a serious treat to the effectiveness of antibiotics, and
accordingly, previously curable infectious diseases reemerge,
posing an increasing public health problem (3–5).
The extrusion of noxious agents which are unrelated in
terms of their chemical structures is catalyzed by so-called
multidrug resistance (MDR)1 transporters. These transporters
can be divided into two major classes on the basis of bioener-
getic and homology criteria: 1) ATP-binding cassette (ABC)
primary active transporters, which utilize the free energy of
ATP hydrolysis to drive substrate transport across the lipid
bilayer; and 2) secondary transporters, which use the proton or
sodium motive force for substrate transport. The latter class
includes most of the bacterial multidrug efflux systems de-
scribed to date (6–9). The former class comprises well charac-
terized eukaryotic MDR transporters such as P-glycoprotein,
MRP1, and BCRP (1, 10, 11). Surprisingly, only few homologs
of eukaryotic ABC-type MDRs have been characterized in bac-
teria: LmrA from Lactococcus lactis (12), BmrA (YvcC) from
Bacillus subtilis (13), and HorA of Lactobacillus brevis (14).
These proteins are believed to function as homodimeric MDR
transporters. Genomic sequences, however, show a ubiquitous
distribution of putative MDR ABC-type pumps (15, 16), but
these systems have not yet been linked to multidrug resistance
in bacteria.
ABC transporters are usually composed of four domains: two
hydrophobic transmembrane domains (TMDs) with typically
six membrane-spanning -helices and two membrane-associ-
ated, hydrophilic nucleotide binding domains (NBDs) (17–19).
The TMDs are believed to accommodate the substrate binding
site(s). The diversity of the substrates transported by members
of ABC transporters is reflected by a low conservation of the
TMDs sequences. In contrast, amino acid sequences of the
NBDs are evolutionarily highly conserved with the Walker A
and B motifs of the ATP binding domain as well as motifs
unique to ABC transporters (i.e. the ABC signature, the histi-
dine, and the glutamine loop) (19, 20). With many bacterial
ABC transporters, the four domains are contained in separate
proteins, whereas in eukaryotes, these domains are mostly
fused to yield a so-called “full-transporter” that accommodates
all domains in a single polypeptide (19, 21). In “half-transport-
ers,” one TMD is fused to an NBD, and these proteins either
homo- or heterodimerize to form the active unit.
The Gram-positive bacterium L. lactis harbors at least two
multidrug transporters (i.e. LmrP, a secondary drug extrusion
system that mediates a drug/H antiport activity, and LmrA,
an ABC MDR transporter). In addition, some strains contain a
plasmid-encoded LmrA homolog termed LmrB that is respon-
sible for the extrusion of the bacteriocin, lactococcin (22).
L. lactis exhibits several different MDR-like transport activi-
ties (23, 24) that are not explained by the presence of the well
characterized transporters LmrA and LmrP. Most importantly,
strains with a deletion of the lmrP (25) or lmrA gene (Fig. 2B)
exhibit an unaltered ability to secrete ethidium from the cell.
This implies that there must be other MDR-like transporters
active in L. lactis that so far have escaped detection. Analysis
of the recently published genome of L. lactis ssp. lactis IL1403
(26) indeed indicates the presence of another MDR-like trans-
port system. Here we report on two open reading frames ydaG
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and ydbA that are predicted to be co-transcribed and that
encode two separate MDR-like half-transporters. The data
demonstrate that YdaG and YdbA heterodimerize to form a
functional MDR transporter. This is the first report on a het-
erodimeric ABC MDR transporter.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Growth Conditions—L. lactis NZ9000 (lmrA)
which lacks the MDR transporter LmrA (22) (a kind gift from O. Gajic
and J. Kok, Department of Genetics, University of Groningen) was used
as a host for expression of pNG8048E-based plasmids with the nisin-
controlled promoter (27). Multidrug-resistant mutants of L. lactis
MG1363 selected for growth in the presence of ethidium (Ethr), dauno-
mycin (Daur), and rhodamine (Rhor) were described by Bolhuis et al.
(23). Cells were grown in M17 medium (Difco) supplemented with 0.5%
(w/v) glucose and 5 g/ml chloramphenicol when necessary.
Recombinant DNA Techniques—DNA manipulation was performed
essentially as described by Sambrook et al. (28). The ydaG and ydbA
genes were amplified by PCR from genomic DNA of L. lactis IL1403.
NcoI and XbaI restriction sites flanking the genes were introduced to
enable cloning into expression vector pNS8048E, resulting in pNSGA.
This plasmid contains both ydaG and ydbA genes under control of the
nisin-inducible promoter with a C-terminal Streptag II on YdbA. ydaG
and ydbA were cloned separately using the same strategy, and this
resulted in the plasmids pNSG and pNSA encoding for YdaG and YdbA
with a C-terminal Streptag II, respectively. All cloned genes were
verified by DNA sequencing to confirm that no PCR-borne mutations
were introduced.
RNA Techniques—RT-PCR was used to assess the expression levels
of ydaG and ydbA in a series of multidrug-resistant mutants of L. lactis
MG1363 (23). Primer sets were chosen to amplify internal fragments of
320, 318, and 375 bp of ydaG, ydbA, and the secY gene, respectively
(Table I). Total RNA was isolated from L. lactis strains using High Pure
RNA isolation kit (Roche Applied Science), and RT-PCR reactions were
performed with ReadyToGo RT-PCR beads according to the manufac-
turer’s guidelines (Amersham Biosciences).
Preparation of Membrane Vesicles—Inside-out membrane vesicles
were prepared from L. lactis NZ9000 (lmrA) harboring different
pNS8048E-based expression vectors. Control cells were transformed
with pNG8048E, and these were subjected to the same treatment. Cells
were grown at 30 °C up to an OD660 of 0.8, and the expression of the
plasmid-encoded genes was induced by the addition of 0.2% (v/v) super-
natant derived from an overnight culture of the nisin-producing strain
L. lactis NZ9700 (10 ng/ml Nisin A). Subsequently, cells were grown
for 2 h, harvested by centrifugation, and washed once with 50 mM
Tris-HCl, pH 7.0. Cells were resuspended in the same buffer and
treated with lysozyme (10 mg/ml). After 30 min at 30 °C, 10 mM of
MgSO4 and 100 g/ml of DNase were added, and the suspension was
passed twice through a French pressure cell (15,000 p.s.i.). Cell debris
was removed by two centrifugation steps at 13,000 g (15 min at 4 °C),
and the inside-out membrane vesicles were collected by ultracentrifu-
gation at 125,000 g for 1 h at 4 °C. The membranes were resuspended
in 50 mM Tris-HCl, pH 7.0, supplemented with 10% glycerol and stored
at 80 °C.
Strep-Tactin Affinity Purification—Inside-out membranes (30
mg/ml total protein) containing overexpressed YdaG-ST II, YdbA-ST II,
both YdaG and YdbA-ST II, or the control were solubilized in 100 mM
Tris-HCl, pH 8.0, 150 mM NaCl, 10% (v/v) glycerol, and 1% (w/v)
dodecylmaltoside. After 30 min on ice, insoluble material was removed
by centrifugation for 20 min at 280,000  g at 4 °C. Subsequently, the
supernatant was subjected to one-step affinity purification on Strep-
Tactin columns according to the manufacturer’s instructions (IBA).
Purified proteins were visualized by an SDS-polyacrylamide gel stained
with SYPRO Ruby Protein Stain Gel (Molecular Probes, Inc., Eugene,
OR) and Western blotting using Strep-Tactin alkaline phosphatase for
detection (IBA).
ATPase Assay—The ATPase activity of purified YdbA and/or YdaG
was determined using a colorimetric method of Lanzetta at al (29). De-
tergent-solubilized proteins were incubated at 30 °C in a buffer containing
50 mM Tris-HCl, pH 7.4, 150 mM NH4Cl, 5 mM MgSO4, 15 mM MgCl2,
0.05% dodecylmaltoside, and 2.5 mM ATP. Samples of 30 l were trans-
ferred to a 96-well microplate every 10 min, and the reaction was termi-
nated by the addition of 150 l of malachite green molybdate reagent.
After 5 min, 34% citric acid was added to facilitate color development.
Absorbance was measured after 50 min of incubation at room tempera-
ture at 600 nm and compared with a phosphorus standard.
Transport Assays—L. lactis cells induced for the various transporters
were washed three times with 50 mM K-HEPES, pH 7.0, and 5 mM
MgSO4. For the daunomycin and BCECF-AM transport assays, the
buffer was supplemented with 25 mM K2SO4. Cells were collected by
centrifugation and resuspended to an OD660 of 0.5 in the buffer for the
fluorescence measurements. For ethidium transport, cells were pre-
energized for 5 min with 20 mM glucose, whereupon ethidium was
added to final concentration of 10 M. The fluorescence of the ethidium
complex with polynucleotides was monitored at excitation and emission
wavelengths of 500 and 580 nm, respectively (30). For BCECF-AM,
pre-energized cells were incubated with the ionophores valinomycin
and nigericin (1 M each) to preclude any interference by the electro-
chemical pH gradient. BCECF-AM was added to a final concentration of
0.5 M, and the fluorescence was monitored at excitation and emission
wavelengths of 502 and 525 nm, respectively. For daunomycin trans-
port measurements, 10 M daunomycin was added to nonenergized
L. lactis cells, and the passive influx of the compound into the cell was
monitored by following the fluorescence quenching upon binding to
polynucleotides. Fluorescence was monitored at excitation and emission
wavelengths of 480 and 590 nm, respectively. Efflux was induced by the
addition of 20 mM of glucose, whereupon the ionophores valinomycin
and nigericin (1 M each) were added to assess the contribution of the
YdbA and YdaG proteins to the daunomycin efflux. Hoechst 33342 (1
M) (Molecular Probes) transport assays were performed with glucose-
energized cells. Fluorescence emission and excitation wavelengths were
at 355 and 457 nm, respectively. All measurements were performed
with a PerkinElmer Life Sciences model 50B fluorometer with magnetic
stirred holder at 30 °C.
Other Techniques—Protein expression levels were determined by
SDS-PAGE and Western blotting using polyvinylidene difluoride mem-
TABLE I
Sequence of primer sets used for RT-PCR









Comparison of amino acid sequence between different MDR systems
Identitya
YdbAb YdaG LmrA BmrA C-Pgp N-Pgp
% % % % % %
YdbA 21.3 22.5 24.4 25.6 25.7
YdaG 21.3 24.2 25.6 22.6 25.0
LmrA 22.5 24.2 42.1 27.1 27.6
BmrA 24.4 25.6 42.1 26.1 29.3
C-Pgp 25.6 22.6 27.1 26.1 38.7
N-Pgp 25.7 25.0 27.6 29.3 38.7
a Percentage of identical residues in pairwise alignments using the ClustalW tool available on the World Wide Web at pbil.ibcp.fr/html/
pbil_index.html.
b Shown are L. lactis YdaG (accession number AAK04408) YdbA (AAK04409), and LmrA (P97046); B. subtilis BmrA (D70031); and the N- and
C-terminal halves (residues 1–640 and 641–1279, respectively) of the human multidrug resistance P-glycoprotein (NP 000918).
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branes. Proteins was detected with Strep-Tactin alkaline phosphatase
conjugates directed against Streptag II (IBA, Germany) and visualized
by chemiluminescence with CDP-Star (Roche Applied Science) and
imaged on a Lumni Imager (Roche Applied Science).
RESULTS
Identification and Overproduction of the ABC Half-trans-
porters YdaG and YdbA in L. lactis—Genome sequencing anal-
ysis of L. lactis ssp. lactis IL1403 (26) revealed the presence of
two adjacent open reading frames that encode ABC half-trans-
porters. The respective gene products YdaG and YdbA show
significant sequence homology to the L. lactis LmrA protein
and other ABC multidrug transporters (Table II), suggesting a
possible role in multidrug resistance. The ydaG and ydbA
genes were amplified by PCR from the L. lactis IL1403 genome
and cloned into the pNS8048E expression vector, which is a
derivative of pNG8048E that allows gene expression under
control of the tightly regulated, inducible nisA promoter (27).
The pNS8048E vector was created by insertion of an XbaI and
HindIII DNA fragment encoding the Streptag II (ST II) and
stop codon into pNG8048E. This allows the in-frame fusion of
the ST II to the 5 termini of the cloned genes, thus yielding the
following expression constructs: 1) pNSG containing ydaG with
a ST II; 2) pNSA containing ydbA with a ST II; and 3) pNSGA
containing both ydaG and ydbA with a ST II localized on YdbA.
The expression vectors were transformed to L. lactis NZ9000
(lmrA), a strain that lacks the lmrA gene and that was used to
preclude any background drug extrusion activity of this trans-
porter. Cells were grown in the presence of nisin to induce the
expression of the various genes, and subsequently, membranes
were isolated for protein expression analysis. Membranes de-
rived from L. lactis NZ9000 (lmrA) harboring pNSG, pNSA, or
pNSGA showed on Coomassie Brilliant Blue-stained SDS-
PAGE the presence of protein bands with the expected molec-
ular sizes: YdaG (63 kDa), YdbA (74 kDa), and YdaG/YdbA,
respectively (Fig. 1A). These polypeptide bands were absent in
membranes derived from L. lactis NZ9000 (lmrA) harboring
the control vector pNG8048E. Western blotting with Strep-
Tactin conjugated to alkaline phosphatase directed against the
ST II (ST II is Streptag) confirmed the presence of the tagged
YdaG and YdbA proteins (Fig. 1B).
YdaG and YdbA Mediate Ethidium Bromide Extrusion from
L. lactis Cells—Ethidium bromide is a toxic compound that is
widely used to detect the activity of multidrug resistance efflux
pumps (25, 31, 32). Ethidium becomes fluorescent upon inter-
calation with DNA, and this property can be used conveniently
to monitor its influx into the cell. The addition of ethidium to
glucose-energized L. lactis NZ9000 cells resulted in a rapid
increase of ethidium fluorescence (Fig. 2B). An identical influx
pattern was observed with L. lactis NZ9000 (lmrA) cells that
lack the wild-type lmrA gene (Fig. 2B), indicating that LmrA
FIG. 1. Overexpression of YdaG,
YdbA, and YdaG/YdbA in L. lactis
NZ9000 (lmrA). A, Coomassie Brilliant
Blue-stained SDS-PAGE gel of inside-out
membrane vesicles (20 g of protein/lane)
prepared from cells harboring the empty
vector (lane 1) or vectors expressing
YdaG/YdbA with an ST II on YdbA (lane
2), YdaG-ST II (lane 3), or YdbA-ST II
(lane 4). B, Western blot of the SDS-
PAGE gel of A stained with Strep-Tactin-
alkaline phosphatase. The arrows indi-
cate the positions of YdaG and YdbA.
YdbA-ST II stained poorly with the Strep-
Tactin-alkaline phosphatase, which is
most likely due to partial truncation of
the carboxyl-terminal tag.
FIG. 2. YdaG- and YdbA-mediated
ethidium efflux from L. lactis. A, ac-
cumulation of ethidium bromide by glu-
cose-energized cells of L. lactis NZ9000
(lmrA) harboring the control plasmid
pNG8048E (line 1) and plasmids for ex-
pression of YdaG (line 2), YdbA (line 3),
and YdaG/YdbA (line 4). B, accumulation
of ethidium bromide in L. lactis NZ9000
(lines 2 and 4) and NZ9000 (lmrA) (lines
1 and 3) in the absence (lines 1 and 2) and
presence (lines 3 and 4) of glucose.
Washed cell suspensions (0.1 mg of pro-
tein/ml) were pre-energized, where neces-
sary, for 5 min with 20 mM glucose as
indicated, whereupon ethidium bromide
was added to a final concentration of 10
M. Fluorescence of ethidium was moni-
tored over time. a.u., arbitrary units.
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does not significantly contribute to ethidium efflux in these
cells. When L. lactis NZ9000 (lmrA) cells were used that
expressed both YdaG and YdbA, a strongly reduced influx of
ethidium was observed. In contrast, overexpression of YdaG or
YdbA alone resulted in a pattern indistinguishable from the
control plasmid and thus did not decrease the influx of
ethidium (Fig. 2A). These observations indicate that both YdaG
and YdbA are needed for active extrusion of ethidium, suggest-
ing that these proteins interact to form a functional
MDR transporter.
YdaG and YdbA Function as a Multidrug Transporter—In
addition to ethidium, several other compounds were tested as
possible substrates for the YdaG and YdbA transporters. The
hydrophobic noncharged ester BCECF-AM is widely used for
intracellular pH measurements. As an ester, BCECF readily
diffuses across the cytoplasmic membrane, whereupon it is
hydrolyzed by a nonspecific esterase that releases the mem-
brane-impermeable fluorescent BCECF in the cytosol (33). Ac-
tive efflux of BCECF-AM by the human multidrug transporter
P-glycoprotein was demonstrated in NIH-3T3 mouse fibro-
blasts. In such assays, extrusion of BCECF-AM was assumed
to occur from the membrane before the compound reached the
cytoplasm, since the hydrolysis by esterases was found to be
not rate-limiting for fluorescence development (34). Moreover,
a multidrug-resistant mutant of L. lactis (Ethr) that shows an
increased resistance to ethidium bromide also rapidly expels
the BCECF-AM in an ATP-dependent manner (24). A rapid
development of BCECF fluorescence was observed when
BCECF-AM was added to L. lactis NZ9000 (lmrA) control
cells or to cells that expressed YdaG or YdbA independently
(Fig. 3). The fluorescence development was greatly reduced
when cells were used that expressed YdaG and YdbA simulta-
neously (Fig. 3). The rate of BCECF-AM influx was not altered
when cells were incubated with the ionophores nigericin and
valinomycin, showing a similar behavior as ethidium-resistant
(or Ethr) L. lactis cells (24) and ruling out a proton motive
force-dependent extrusion mechanism.
The antitumor drug daunomycin is excreted by several hu-
man MDR transporters including P-glycoprotein, MRP1, and
BCRP (for reviews, see Refs. 1 and 10). Furthermore, a high
rate of daunomycin efflux was observed from an ethidium-
resistant strain of L. lactis (23). The fluorescence of daunomy-
cin is quenched upon binding to polynucleotides, and this fea-
ture can be used to monitor its influx. When daunomycin is
added to L. lactis cells, a rapid fluorescence increase is ob-
served due to the addition of drug followed by a drop in the
fluorescence signal caused by entrance of the drug into the cell
and binding to intracellular polynucleotides. Upon energiza-
tion of the cells with glucose, all tested strains exhibited sim-
ilar rates of daunomycin efflux (Fig. 4). However, upon the
addition of the ionophores valinomycin and nigericin, which
dissipate the proton motive force, only cells expressing both
YdaG and YdbA were able to maintain a high fluorescence level
FIG. 3. YdaG- and YdbA-mediated BCECF extrusion from
L. lactis cells. BCECF-AM influx was measured with L. lactis NZ9000
(lmrA) cells harboring the control plasmid pNG8048E (line 1) and
plasmids encoding YdaG (line 2), YdbA (line 3), and YdaG/YdbA (line 4).
Washed cell suspensions (0.1 mg of protein/ml) were pre-energized for 5
min with 20 mM glucose in the presence of the ionophores valinomycin
and nigericin (1 M each). After the addition of BCECF-AM (0.5 M), the
BCECF fluorescence was followed in time. a.u., arbitrary units.
FIG. 4. YdaG- and YdbA-mediated
daunomycin transport in L. lactis
cells. Transport of daunomycin by L. lac-
tis NZ9000 (lmrA) cells harboring the
control plasmid pNG8048E (solid line)
and plasmids encoding YdaG (dashed
line), YdbA (dashed and dotted line), and
YdaG/YdbA (dotted line). To a washed cell
suspension (0.2 mg/ml), 10 M daunomy-
cin was added and the influx of daunomy-
cin was followed in time as a quenching of
the fluorescence by the binding to DNA.
As indicated by the arrow, cells were en-
ergized with glucose to initiate the extru-
sion of daunomycin. Valinomycin and ni-
gericin were added to discriminate
between the endogenous proton motive
force-dependent efflux activity and the ac-
tivity of YdaG/YdbA. a.u., arbitrary units.
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(Fig. 4). These data indicate that YdaG plus YdbA mediates
efflux of daunomycin.
Another widely used substrate for MDR transporters is the
lipophilic compound Hoechst 33342 (13, 30, 35–37). Hoechst
33342 is a membrane-permeable nuclear stain that becomes
fluorescent upon intercalation in the lipophilic membrane en-
vironment and upon binding to DNA (37). The addition of
Hoechst 33342 to glucose-energized cells of L. lactis NZ9000
(lmrA) control cells results in a rapid increase in fluorescence,
which is most likely due to binding of the drug to double-
stranded DNA (Fig. 5). However, when cells are used that
overexpress YdaG and YdbA, the fluorescence development of
the drug is greatly reduced, suggesting that Hoechst 33342 is
actively exported by the YdaG/YdbA transporter. Cells overex-
pressing YdbA show a fluorescence development that is similar
to the control, whereas cells overexpressing YdaG reproducibly
exhibited a slightly lower level of Hoechst 33342 accumulation
(Fig. 5). Taken together, these data demonstrate that YdaG
and YdbA constitute a functional MDR transporter in L. lactis.
YdaG and YdbA Co-purify as a Heterodimer—Since YdaG
and YdbA are both needed for the extrusion of various fluores-
cent compounds, it is likely that they form a heterodimer as a
functional unit. To investigate whether YdaG and YdbA form
stable dimers, a co-purification method was used. For this
purpose, membranes were isolated from cells harboring the
control vector or vectors that encode for YdaG and YdbA either
independently or together. These constructs contained an ST II
either on YdbA or on YdaG, whereas the co-expressed YdaG
and YdbA harbored a ST II tag on YdbA only. Membranes were
solubilized with dodecylmaltoside and subjected to one-step ST
II affinity chromatography. Samples were analyzed by SDS-
PAGE and Western blotting (Fig. 6, A and B). YdaG and YdbA
migrate on SDS-PAGE as proteins with molecular masses of 63
and 74 kDa, respectively (Fig. 6A, lanes 2 and 4). When YdbA
was purified from membranes containing both YdaG and
YdbA-ST II, two polypeptide bands were obtained with molec-
ular masses that corresponded to YdaG and YdbA, respectively
(Fig. 6A, lane 3). The identity of these polypeptides was con-
firmed by Western blotting (Fig. 6B). From the relative inten-
sities of YdbA and YdaG in the SYPRO Ruby-stained gel, it
appears that both proteins are present in stoichiometric
amounts, indicating the presence of a stable heterodimer.
The YdaG/YdbA Heterodimer Displays ATPase Activity—
Our data show that YdaG and YdbA interact with each other to
form a complex that can be purified, whereas both proteins are
required to transport a range of unrelated drugs. To further
explore whether both half-transporters are needed to form a
functional unit, ATPase activity measurements were per-
formed with the purified proteins. Only the co-purified complex
of YdbA and YdaG showed a high ATPase activity, whereas the
individual YdbA or YdaG proteins were essentially inactive
(Fig. 7). These data further strengthen the notion that both
proteins are required to form an active transporter.
ydaG and ydbA Are Up-regulated in Multidrug-resistant
Strains of L. lactis—Previously, multidrug-resistant strains of
FIG. 5. YdaG- and YdbA-mediated Hoechst 33342 extrusion
from L. lactis cells. Shown is transport of Hoechst 33342 by L. lactis
NZ9000 (lmrA) cells harboring the control plasmid (line 1) and the
control plasmids for expression of YdaG (line 2), YdbA (line 3), and
YdaG/YdbA (line 4). Cells were pre-energized for 5 min with glucose,
whereupon 1 M Hoechst 33342 was added. The fluorescence of Hoechst
33342 was followed in time. The cells expressing YdaG reproducibly
(four independent experiments) exhibited a slightly elevated extrusion
activity relative to control cells or cells expressing YdbA. a.u., arbitrary
units.
FIG. 6. YdaG and YdbA co-purify as a heterodimer. A, SYPRO Ruby-stained SDS-PAGE of Streptag II affinity-purified protein from
membranes derived from control cells (lane 1) or from cells expressing YdaG-ST II (lane 2), YdaG and YdbA-ST II (lane 3), or YdbA-ST II (lane 4).
B, Western blot of SDS-PAGE gel of A stained with Strep-Tactin alkaline phosphatase. The arrows indicate the positions of YdaG and YdbA.
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L. lactis ssp. lactis MG1363 were selected for growth in the
presence of high concentrations of ethidium bromide, dauno-
mycin, and rhodamine 6G. The resulting mutants were found
to be cross-resistant to a wide variety of structurally unrelated
toxic compounds including the various selective drugs and qui-
nine (23). To test whether ydaG and ydbA are involved in the
multidrug resistance phenotype in L. lactis, we investigated
their mRNA levels in the wild type and multidrug-resistant
strains using an RT-PCR method. Both transporter genes are
significantly up-regulated in all multidrug-resistant strains
(Fig. 8). The expression of the secY gene was used as a control
(Fig. 8). These results further support the hypothesis that the
half-transporters YdbA and YdaG constitute a MDR het-
erodimeric transporter.
DISCUSSION
When L. lactis cells are challenged with increasing amounts
of toxic compounds, mutants are obtained that are cross-resis-
tant to a wide spectrum of structurally diverse drugs, many of
which are typical substrates of the mammalian P-glycoprotein.
This resistance is to a large extent due to the active secretion of
these compounds from the cells. Previous biochemical and
bioenergetic studies revealed that L. lactis contains at least two
MDR transporters (i.e. the secondary transporter LmrP and
the ABC transporter LmrA). The multidrug resistance pheno-
type of L. lactis mutants involves both proton motive force and
ATP-dependent transport systems (23), but the exact identities
of the systems responsible have remained obscure. Both LmrA
and LmrP have been implicated in ethidium efflux in L. lactis,
but a single deletion of lmrP (25) or lmrA (Fig. 2B) gene does
not alter the ability of cells to extrude ethidium. So far, the
presence of additional MDR-like transporters in L. lactis has
not been explored. This prompted us to analyze the L. lactis
IL1403 (26) genome for putative MDR pumps whose activity
may contribute to the multidrug resistance phenotype in this
organism. On the basis of homology with described MDR
pumps such as human P-glycoprotein, LmrA of L. lactis, and
BmrA of B. subtilis, we identified two new putative MDR
transporters-encoding genes named ydaG and ydbA. These two
genes are located on the chromosome next to another and are
transcribed in the same direction. These genes have been pre-
dicted to form one co-transcribed unit (operon prediction avail-
able on the World Wide Web at www.tigr.org), and a similar
genetic organization was observed in L. lactis strain MG1363.2
The hydropathy profiles of the amino acid sequences and ho-
mology search suggest that both encode so called half-trans-
porters possessing six putative membrane-spanning segments
followed by cytoplasmically localized NBD domain.
To determine the function of YdaG and YdbA, the proteins
were overproduced in L. lactis independently or together, using
the nisin-inducible system. Next, the transport of a series of
known fluorescent MDR substrates was tested. Strikingly,
L. lactis cells overexpressing both YdaG and YdbA showed
dramatically reduced levels of ethidium accumulation, which
was not observed when the proteins were expressed independ-
ently. Similar results were obtained with the fluorescent dyes
BCECF-AM, daunomycin, and Hoechst 33342. With the last
substrate, a reproducible low activity was observed when YdaG
was expressed independently of YdbA. Transport of these
drugs seems to occur independently of the proton motive force,
since the presence of the ionophores valinomycin and nigericin,
which dissipate the  and pH, respectively, affected trans-
port only marginally. This is consistent with the presumed ATP
dependence of the transport function, which can be predicted
on the basis of the presence of a NBD in both proteins. Our data
suggest that YdaG and YdbA need to dimerize to form a func-
tional ABC transporter. Evidence for heterodimerization was
obtained by the observation that the proteins co-purify in a
stoichiometric manner when subjected to affinity chromatog-
raphy with only one of the proteins tagged. Moreover, the
co-purified heterodimeric complex effectively hydrolyzes ATP,
whereas separately purified YdbA or YdaG proteins exhibit
only a minor ATPase activity. The later activity may arise from
homodimer formation or alternatively from a minor fraction of
heterodimer formation with the endogenous levels of YdaG or
YdbA, respectively. Substrate such as ethidium and Hoechst
33342 did not stimulate the ATPase activity of the YdaG/YdbA
heterodimer.3 Lack of stimulation may be due to the already
activated state of the transporter, or alternatively, the deter-
gent-solubilized state might support this activated state. Sim-
ilar observations have been reported for P-glycoprotein, where
a low level of substrate activation of its ATPase activity was
observed only for the membrane-reconstituted form of P-glyco-
protein and not for the detergent-solubilized state (38). These
2 J. Lubelski and R. van Merkerk, unpublished data. 3 J. Lubelski, unpublished results.
FIG. 7. ATPase activity of purified YdaG/YdbA, YdaG, and
YdbA. Basal ATPase activity was measured as the release of Pi in time
by an elution fraction containing YdaG and YdbA complex, YdaG, or
YdbA as described under “Experimental Procedures.”
FIG. 8. Expression of ydbA and ydaG in L. lactis MG1363 and
derived multidrug resistance strains. The expression of ydbA,
ydaG, and the control secY gene was measured by RT-PCR using spe-
cific primer pairs and total RNA isolated from the parental L. lactis
MG1363 (lane 4) and multidrug resistance derivatives obtained after
selection by growth in the presence of ethidium (lane 1), daunomycin
(lane 2), and rhodamine (lane 3).
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questions will be addressed in future reconstitution studies.
In the cell, the multidrug resistance phenotype is often the
result of several mechanisms, which may include various
transporter systems. In particular, when cells are challenged
with an increasing concentration of drugs, the emerging MDR
phenotype may be a consequence of the elevated expression of
various MDR transporters and/or mutations that affect the
drug recognition spectrum. Strikingly, studies with wild type
strains that contain either a deletion of the lmrA (this study) or
lmrP gene (25) showed that the ethidium resistance and extru-
sion capacity of such cells remains unaltered questioning the
importance of these two genes in the endogenous ethidium
resistance of these cells. The lack of a drug-sensitive phenotype
has been attributed to the elevated expression of other un-
known drug transporters, but the identity of these systems has
remained obscure. LmrP has been shown to effectively excrete
ethidium (39), but since this protein is expressed only in the
late logarithmic growth phase4 it may not contribute to the
drug resistance profile of the cells at the initiation of growth.
Moreover, in contrast to previously published reports (30, 40–
42), we do not observe an increased ethidium efflux rate from
L. lactis NZ9000 wild type or lmrA cells that overexpress the
LmrA protein.5 In a parallel experiment, overexpression of
both YdaG and YdbA in L. lactis NZ9000 results in a marked
ethidium extrusion (see also Fig. 2), which clearly marks this
system as an ethidium extrusion system. We also noted an
elevated expression of both ydaG and ydbA in several unre-
lated drug-resistant strains, among which is the ethidium-
resistant L. lactis strain. The drug extrusion activities as ob-
served in the ethidium-resistant strain were previously found
to be insensitive to ionophores (23), which further suggests a
role of YdaG and YdbA in the drug resistance. We cannot
exclude the possibility that other drug transporters contribute
to the drug resistance of these selected strains. However, both
the functional assays and expression studies suggest that
YdaG/YdbA contribute to the drug resistance patterns of the
selected resistant L. lactis strains.
The active form of an ABC transporter usually constitutes
four domains (i.e. two TMDs and two NBDs) (43). These pro-
teins can exist either as a single polypeptide, as separate do-
mains, or as fused domains in various organizational units.
ABC half-transporters consist of a TMD fused with NBD, and
they are believed to homo- or heterodimerize to form a full ABC
transporter (44). Homodimerization has been experimentally
demonstrated for several half-transporters, such as LmrA (40)
and MsbA of Escherichia coli (45). There are several examples
of eukaryotic ABC transporters that heterodimerize to form a
functional unit such as, for instance, TAP1/TAP2, an ABC
transporter associated with antigen presentation (46), and the
Drosophila white, brown, and scarlet genes responsible for
transport of pigment precursor to the eye (47). In the latter
case, the substrate specificity depends on the heterodimerizing
partner brown, scarlet, or white. Half-transporters localized in
peroxisomes that belong to the ABCD subfamily, namely adre-
noleukodystrophy protein, adrenoleukodystrophy-related pro-
tein, and peroxisomal protein of 70 kDa, were shown to homo-
and heterodimerize as suggested by yeast two-hybrid studies.
Accordingly, it was proposed that different combinations of
such dimers vary in the substrate spectrum (48). Our data
suggest that YdaG and YdbA heterodimerize to form an active
MDR transporter. We therefore propose to rename YdaG and
YdbA as the lactococcal multidrug resistance protein C (LmrC)
and D (LmrD), respectively. Future studies will address the
question whether LmrC and LmrD can also form homodimers
and, if so, to what extent their substrate specificities differ from
the LmrCD heterodimer.
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